Bcworldpharm Co Ltd

XKRX:200780 (Korea (the Republic of))  
â‚© 5880.00 (+2.26%) Jun 4
58.22
P/B:
0.62
Market Cap:
â‚© 49.62B ($ 36.09M)
Enterprise V:
â‚© 131.56B ($ 95.68M)
Volume:
6.08K
Avg Vol (2M):
7.97K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Bcworldpharm Co Ltd ( XKRX:200780 ) from 2014 to Jun 04 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Bcworldpharm stock (XKRX:200780) PE ratio as of Jun 04 2024 is 58.22. More Details

Bcworldpharm Co Ltd (XKRX:200780) PE Ratio (TTM) Chart

To

Bcworldpharm Co Ltd (XKRX:200780) PE Ratio (TTM) Historical Data

Total 1271
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Bcworldpharm PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-05 58.2 2024-03-28 67.7
2024-06-04 58.2 2024-03-27 22.0
2024-06-03 56.9 2024-03-26 22.1
2024-05-31 57.3 2024-03-25 22.1
2024-05-30 57.2 2024-03-22 22.0
2024-05-29 58.6 2024-03-21 21.8
2024-05-28 59.4 2024-03-20 21.5
2024-05-27 59.5 2024-03-19 21.5
2024-05-24 60.1 2024-03-18 21.5
2024-05-23 60.4 2024-03-15 21.4
2024-05-22 60.8 2024-03-14 21.4
2024-05-21 60.6 2024-03-13 21.8
2024-05-20 60.2 2024-03-12 22.3
2024-05-17 61.0 2024-03-11 21.6
2024-05-16 60.8 2024-03-08 21.7
2024-05-14 60.7 2024-03-07 21.5
2024-05-13 61.3 2024-03-06 21.4
2024-05-10 61.4 2024-03-05 21.3
2024-05-09 61.2 2024-03-04 21.2
2024-05-08 61.0 2024-02-29 21.0
2024-05-07 60.6 2024-02-28 20.9
2024-05-03 60.9 2024-02-27 20.4
2024-05-02 61.0 2024-02-26 20.8
2024-04-30 60.9 2024-02-23 21.3
2024-04-29 61.1 2024-02-22 21.3
2024-04-26 61.7 2024-02-21 21.1
2024-04-25 61.5 2024-02-20 20.9
2024-04-24 62.0 2024-02-19 21.0
2024-04-23 61.8 2024-02-16 21.0
2024-04-22 60.3 2024-02-15 20.9
2024-04-19 60.3 2024-02-14 20.7
2024-04-18 61.4 2024-02-13 20.7
2024-04-17 60.2 2024-02-08 20.6
2024-04-16 59.8 2024-02-07 20.4
2024-04-15 62.6 2024-02-06 20.3
2024-04-12 62.8 2024-02-05 20.4
2024-04-11 62.4 2024-02-02 20.2
2024-04-09 64.2 2024-02-01 20.4
2024-04-08 64.4 2024-01-31 20.4
2024-04-05 65.7 2024-01-30 20.9
2024-04-04 65.6 2024-01-29 20.7
2024-04-03 65.8 2024-01-26 20.8
2024-04-02 65.6 2024-01-25 20.6
2024-04-01 66.7 2024-01-24 20.8
2024-03-29 66.9 2024-01-23 20.9

Bcworldpharm Co Ltd (XKRX:200780) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Bcworldpharm Co Ltd is a pharmaceutical company. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics. The products are offered under ALIMA Inj, AROXOL Tab, ASCORBIC Inj and BC CITICOLINE Inj brands.